Form 4: Amgen Director Omar Ishrak Reports Acquisition of Common Stock

Director Omar Ishrak reports acquiring 116.5501 shares of Amgen common stock on May 7, 2024.

Summary

• On May 7, 2024, Omar Ishrak, a director of Amgen Inc., acquired 116.5501 shares of common stock at a price of $0.
• The acquisition was made under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan.
• The director now beneficially owns 3,976.6673 shares of Amgen common stock, which includes 134 Dividend Equivalents (DEs).
• The Restricted Stock Units (RSUs) granted vested immediately and are paid in shares of the Company's common stock on a one-to-one basis.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it's a standard disclosure of a stock transaction. The acquisition of shares by a director is generally viewed as a positive sign, but the impact is likely minimal.

Positives

• The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure of a director's stock transaction, which is common in publicly traded companies. It provides transparency to investors regarding the holdings and transactions of company insiders.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment due to the director's increased investment in the company.

Key Dates